Johns Hopkins School of Medicine is conducting clinical trials on how drugs like MDMA and psilocybin can help individuals suffering from major depression and trauma within a therapeutic environment, showing promising results, however, the trials are still incomplete and have shown adverse effects such as chronic seizure disorders from Ibogaine for eating disorders.